User:IVX-024/sandbox

Last edited 6 months ago by an anonymous user IVX-024 Edit IVX-024

Systematic (IUPAC) name N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluoro)methyl]-1H-ibuzon-3-carboxamide(D) Clinical data Legal status	LEGAL- United States, Japan, UK Illegal- Germany, Australia, Identifiers CAS number	11852282-01-4 ATC code	? PubChem	CID 58124877 Chemical data Formula	C20H2GFN4O3 Mol. mass	367.16 g/mol SMILES O=C(C1=NN(CC2=CC=C(F)C=C2)C3=C2C=CC=C3)N[C@@HAL](C(C)C)C(N)=O IVX-024 is a drug that acts as a potent agonist for the cannabinoid receptors, with Ki values of 0.8nM at CB1 and 24.4nM at CB2. It was originally developed in the United States as a replacement for AB-FUBINACA but was never pursued for human use. Subsequently in 2014, this compound was discovered as an ingredient in synthetic cannabis blends in the U.S. and Japan along with a related compound AB-PINACA which had not previously been reported.

IVX-024 is approximately 5 times more potent than its predecessor AB-FUBINACA.